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Background: Based on European recommendations of ESPGHAN/ESPID from 2008, first line therapy for
dehydration caused by acute gastroenteritis (AGE) is oral rehydration solution (ORS). In case of oral route failure,
nasogastric tube enteral rehydration is as efficient as intra-venous rehydration and seems to lead to fewer adverse
events. The primary objective was to describe rehydration strategies used in cases of AGE in pediatric emergency
departments (PEDs) in Belgium, France, The Netherlands, and Switzerland.
Methods: An electronic survey describing a scenario in which a toddler had moderate dehydration caused by AGE
was sent to physicians working in pediatric emergency departments. Analytical data were analyzed with descriptive
statistics and Kruskal –Wallis Rank test.
Results: We analyzed 68 responses, distributed as follows: Belgium N = 10, France N = 37, The Netherlands N = 7,
and Switzerland N = 14. Oral rehydration with ORS was the first line of treatment for 90% of the respondents. In
case of first line treatment failure, intravenous rehydration was preferred by 95% of respondents from France,
whereas nasogastric route was more likely to be used by those from Belgium (80%), The Netherlands (100%) and
Switzerland (86%). Serum electrolyte measurements were more frequently prescribed in France (92%) and Belgium
(80%) than in The Netherlands (43%) and Switzerland (29%). Racecadotril was more frequently used in France, and
ondansetron was more frequently used in Switzerland. No respondent suggested routine use of antibiotics.
Conclusion: We found variations in practices in terms of invasiveness and testing. Our study supports the need for
further evaluation and implementation strategies of ESPGHAN/ESPID guidelines. We plan to extend the study
throughout Europe with support of the Young ESPID Group.
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Acute gastroenteritis (AGE) in children is very common
and accounts for a large number of emergency depart-
ment visits and hospitalizations [1]. The most dangerous
complication is dehydration, and every year, there are at
least 230 deaths and over 87,000 hospitalizations of chil-
dren under 5 years of age in the European Union [2]. In* Correspondence: francois.angoulvant@nck.aphp.fr
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unless otherwise stated.Europe, incidence of AGE range from 0.5 to 1.9 episodes
per year per person, with a higher risk for children under
3 years [3]. The management of children diagnosed with
AGE is based largely upon international recommen-
dations. The latest European recommendations from
European Society for Paediatric Gastroenterology Hepa-
tology and Nutrition/European Society for Paediatric
Infectious Disease (ESPGHAN/ESPID) published in 2008
[3,4], specify preferred methods of rehydration, possible
medications, potentially useful laboratory tests, and sug-
gested nutrition in cases of AGE. These recommendations
clearly state that the first line of treatment should include
oral rehydration with standard Oral Rehydration Solution. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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same recommendations [3]. In contrast, treatment recom-
mendations are less strict regarding second line treatments.
Indeed, recommendations indicate that the nasogastric
(NG) and intravenous (IV) routes can both be used to re-
hydrate individuals with AGE even though the recommen-
dations additionally state that the NG route is associated
with less adverse events and shorter hospitalizations [5, 6].
They also clearly state that there is no need for microbio-
logical investigation since the epidemiology of AGE is well
known in Europe [3]. These recommendations, however,
do not take into account the most recent studies on AGE
treatments, such as the study of ondansetron by Carter
et al. [7]. Where guidelines are vague or evidence is lim-
ited, wide variations in the management of AGE have been
observed among institutions and countries [8,9]. Because
an accurate understanding of current treatment regimens
is a necessary prerequisite to developing improvements, we
sought to assess variations in the management of pediatric
AGE across Europe.
Our primary objective was to determine the extent to
which significant variations in rehydration therapies
for individuals with pediatric gastroenteritis exist among
pediatric emergency departments (PEDs) in Europe. Sec-
ondary objectives included the assessment of variations in
the use of additional therapeutic and diagnostic modalities.
Methods
Study design
This study is a cross-sectional electronic survey of physi-
cians regarding their management of pediatric AGE. Par-
ticipants included practicing physicians within PEDs of
teaching hospitals in Belgium, France, The Netherlands
and Switzerland.
Population
We chose to conduct the study in those 4 countries due
to their geographical and linguistic proximity. We se-
lected primarily teaching hospitals because smaller hos-
pitals often consider those facilities as reference sources.
Our survey was sent to both senior, junior physicians
and residents. Every center was asked to include at least
3 participants to improve the measurement representa-
tiveness. All participants who responded were included
in the analyses. An initial power analysis determined that
at least 40 centers should be included with 3 physicians
per center (120 participants).
Survey
Following the recommendations from Burns et al., we
performed a literature review and consulted an expert
panel to assist in item generation to create a self-report
questionnaire containing 24 items [10]. Another panelwas recruited to pretest the survey; their responses were
not included in the data analysis.
The survey began with a brief scenario describing a
toddler presenting with AGE and moderate dehydration
(Additional file 1). Eight survey items collected demo-
graphic information, including country and city of prac-
tice, the number of year of experience in PED and the
number of visits per year. Additional survey items in-
cluded questions about treatments for AGE in PEDs.
Different types of response modalities were utilized, in-
cluding dichotomous questions (yes/no) and questions
addressing the frequency of endorsement with numeric
response options (<5%, 5-30%, 31-69%, 70-95%, >95%).
The items were independent and non-compulsory.
Procedure
The study was conducted between February and July 2012.
The survey was emailed to participants following a phone
contact to increase the potential for a large number of
responses and was accessible in both English and French
on a dedicated website (https://sites.google.com/site/
hydragast/). A reminder was sent to a non-respondent’s
facility 3 weeks after sending the first e-mail. If we had
only one response from a particular facility, an additional
reminder was sent in hopes of acquiring other responses
from the same center.
Data analysis
Data were analyzed using the statistical software Stata
(StataCorp LP, College Station, Texas, USA). To determine
the preferred treatment (frequency ≥ 70%), responses were
grouped by frequency of endorsement questions in two
categories. This decision was driven by the distribution of
the data and ease of interpretation [9]. Categorical data
were analyzed using the Kruskal-Wallis rank test, and
other data were analyzed via descriptive analysis, with each
country being analyzed separately. Subsequently, because
of potential response homogeneity, countries were clus-
tered for analysis using the Wilcoxon rank sum test. Ap-
proval from the Ethics committee was not needed because
this study is reflective of opinions more than actual prac-
tice and no real patients were included.
Results
Description of participants
We sent the survey to 17 centers in France, 6 in
Belgium, 12 in Switzerland and 7 in The Netherlands. 68
surveys were completed and returned, and all were ana-
lyzed. The response rate when we compare the number
of answers received to the number of answers expected
from the power analysis is 54%. We received 37 surveys
from 14 centers in France, 10 surveys from 6 centers in
Belgium, 14 surveys from 6 centers in Switzerland and 7
surveys from 3 centers in The Netherlands, yielding an
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were 7 juniors and 61 seniors. Table 1 includes item re-
sults relative to the frequency of endorsement.
First line rehydration therapy
Ninety percent of respondents (N = 61) reported the use
of oral route ORS as their first line of rehydration therapy
in children with moderate dehydration caused by infec-
tious AGE. There was no significant difference among
countries. Non-modified ORS was chosen as the primary
liquid for oral rehydration by 91% (N = 62) of respondents.
Second line rehydration therapy
In the case of oral rehydration failure, while IV rehydra-
tion was the preferred second line treatment for 95%
(N = 35) of respondents in France, no respondent from
the 3 other countries reported a preference for IV rehydra-
tion in such cases (P < 0.001; Wilcoxon rank sum test).
In contrast, NG rehydration was the preferred second line
treatment of respondents in Belgium, 80% (N = 8); The
Netherlands, 100% (N = 7); and Switzerland, 86% (N = 12);
whereas only one respondent (3%) in France reported itTable 1 Preferential practices regarding management of pedi




ORS oral route 61 (90%)
CI [80–96]
ORS pure 62 (91%)
CI [82–97]
Rehydration route in case of oral rehydration failure
Intra-venous route 35 (51%)
CI [39–64]
Nasogastric route (with ORS) 28 (41%)
CI [29–54]





Laboratory tests in case of oral rehydration failure
Electrolytes 49 (72%)
CI [60–82]
Blood count 28 (41%)
CI [29–54]
C-reactive protein 25 (37%)
CI [25–49]
Stool virology 20 (29%)
CI [19–42]
Stool culture 11 (16%)
CI [8–27]as his preferential treatment (P < 0.001; Wilcoxon rank
sum test).
Results describing the composition of fluids in the case
of IV rehydration were widely heterogeneous, with over
15 different combinations reported by respondents. In 4
cases, respondents reported choosing not to use standard
fluid in favor of utilizing hand-made fluid adapted specific-
ally to each patient. However, normal saline (0.9% NaCl)
was the most frequently used fluid reported (N = 10/27,
37%) in Belgium, The Netherlands and Switzerland. In
France, 56% of the participants (N = 18/32) reported fre-
quently using a fluid composed of 5% glucose with 4 g/L
NaCl and 2 g/L KCl. The volume of fluid administered
during the first 4 hours in cases of IV rehydration was
also widely heterogeneous, with responses ranging from
10 mL/kg to 100 mL/kg and a median of 15 mL/kg.
Laboratory testing
80% (N= 8) of respondents from Belgium, 92% (N = 34) of
respondents from France, 43% (N = 3) of respondents from
The Netherlands and 29% (N = 4) of respondents from
Switzerland, conducted tests for serum electrolyte in moreatric acute gastroenteritis
Belgium The Netherlands Switzerland France
N = 10 N = 7 N = 14 N = 37
10 (100%) 5 (71%) 12 (86%) 34 (92%)
10 (100%) 6 (86%) 13 (93%) 33 (89%)
0 (0%) 0 (0%) 0 (0%) 35 (95%)
8 (80%) 7 (100%) 12 (86%) 1 (3%)
0 (0%) 1 (14%) 5 (36%) 0 (0%)
0 (0%) 0 (0%) 0 (0%) 19 (51%)
8 (80%) 3 (43%) 4 (29%) 34 (92%)
6 (60%) 2 (29%) 1 (7%) 19 (51%)
6 (60%) 2 (29%) 1 (7%) 16 (43%)
5 (50%) 2 (29%) 1 (7%) 12 (32%)
2 (20%) 3 (43%) 0 (0%) 6 (16%)
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for viruses more than 70% of the time by only 29% (N =
20) of the respondents, and stool cultures were performed
by 16% (N = 11) of the respondents. A blood count and/or
C-reactive protein was performed by 46% (N = 31) of
respondents; only 4 respondents reported testing blood
count only, and one respondent reported testing C-reactive
protein only. Other laboratory tests reported by the partici-
pants, but not listed in our questionnaire, included a urine
stick test, tests for ketonemia, abdominal ultrasonography
and an arterial blood gas test.
Drug prescription
Antiemetic agents, such as ondansetron, metoclopramide,
domperidone, were rarely reported to be prescribed ac-
cording to respondents. Among those drug types, ondan-
setron was reported the most frequently, by 9% (N = 6) of
respondents, most of whom were from Switzerland (N =
5). No respondent reported the use of antimotility (lopera-
mide) drugs. Probiotics were reported as prescribed more
than 70% of the time by only one respondent. Fifty-one
percent (N = 19) of the respondents from France reported
prescribing an antisecretory drug (racecadotril) more than
70% of the time, but no such use was reported by physi-
cians in the other countries (P < 0.001; Wilcoxon rank
sum test). Antibiotics were reported as never prescribed
by 87% (N = 59) of respondents. None of the respondent
reported the preferential use of adsorbent (smectite).
Nutrition
Survey reports of food withdrawal duration varied from
2 hours to 24 hours, with a median of 6 hours.
Discussion
Our study is the first to use a self-report questionnaire
to assess and compare physician practice patterns in the
treatment of pediatric AGE in European PEDs. The results
suggest that the first line of rehydration therapy recommen-
dations are well known, with the use of oral rehydration
with ORS reported by 90% of the respondents, without
variation, across Belgium, France, The Netherlands and
Switzerland. These frequencies are larger than those re-
ported by Freedman et al. in North-America: only 76% of
Canadian physicians and 46% of Americans reported oral
rehydration as their first line of rehydration therapy [9].
Wide practice variations were observed for second line
rehydration treatments and for the type and volume of
fluid reported for IV rehydration. This finding reflects
the variability of European recommendations on this
subject because two equivalent rehydration routes were
reported [3]. However, less within-country variability in
the type of IV or NG rehydration was observed, suggesting
an influence of training and health care organization, spe-
cific to each country, on physician practices [9]. Hoekstrain Australia and New-Zealand [11], and Karpas in Canada
[12], have also shown differences in practice after ORS
failure in different hospitals within the same country.
Among the four countries examined for this study, re-
spondents from France were the ones who most often
chose the IV route and ordered serum electrolyte testing,
a finding possibly explained by the recommendation to
monitor IV rehydration [3]. Microbiological examinations
were commonly reported in our study even though these
exams are not routinely recommended for children with
AGE [3]. Few drugs were reported to be frequently pre-
scribed, and these varied across countries. Despite the lack
of recommendations, the use of racecadotril was fre-
quently reported by French respondents, whereas the use
of ondansetron was reported often by Swiss respondents.
The recommendations concerning laboratory testing and
medication are maybe less known than the ones concern-
ing the rehydration.
Overall, our results suggest that interventions to increase
the homogeneity of practices in the management of
pediatric AGE could be useful [13], especially regarding ad-
juvant therapy such as racecadotril use and laboratory test-
ing. Similarly, in light of the benefits of NG rehydration in
terms of costs and side effects, the implementation of this
method should be considered in France. Despite current
recommendations [3], ondansetron use was frequently re-
ported by respondents in Switzerland. This treatment does
seem to facilitate oral rehydration [14], and some evidence
was not available when the European recommendations
were published in 2008. Nonetheless, a real risk/benefit as-
sessment of the widespread use of ondansetron in AGE in
Europe is still lacking. Studies have shown that parents
prefer IV rehydration [12] and treatments that shorten
diarrhea duration [15]. With respect to health care pro-
viders, another recent study indicated that only 14% of
physicians favor NG over IV rehydration [16]. These ele-
ments highlight the need to refine the current recommen-
dations for the management of pediatric AGE to avoid
unfounded practice variations.Two major issues should
be redefined: to favor one treatment over the other for
the second line rehydration therapy; and to update the
pharmacological therapy statement, especially concerning
the use of ondansetron, based on the recent evidences [7].
Limitations
The low response rate (54%) could have introduced a
self-selection bias. Likewise, the low number of respon-
dents (68) limits the external validity of the study. Most
participants worked in a teaching hospital, which may
not be representative of the entire health care structures
that treats children’s AGE. Additionally, this study is re-
flective of opinions more than actual practice patterns
because it is difficult to determine what respondents ac-
tually do versus what they claim they do.
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We observed good adherence to the European guidelines
for treating AGE in the 4 countries, especially concern-
ing first line therapy and nutrition. However, our study
highlights wide variations in second line rehydration
strategies and drug prescriptions among countries. We
plan to extend this study to other European countries
with the help of the Young ESPID group.
Additional file
Additional file 1: Survey on the practices of physician in the
Emergency Department to rehydrate children with acute
gastroenteritis.
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